Ligand validation:6YU7

LMT: DODECYL-BETA-D-MALTOSIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6YU7_LMT_A_502	33%	61%	0.126	0.914	0.68	0.81	-	-	0	0	37%	0.3714
6YU7_LMT_A_503	15%	60%	0.2	0.873	0.68	0.86	-	-	1	0	37%	0.3714
6YU7_LMT_A_501	13%	44%	0.226	0.766	1.15	1.01	2	1	0	0	100%	1
6YU6_LMT_B_504	52%	44%	0.145	0.901	1.14	1.03	2	3	0	0	100%	1
6YU3_LMT_A_705	23%	60%	0.15	0.888	0.65	0.89	-	-	0	0	37%	0.3714
6YU4_LMT_A_711	21%	40%	0.187	0.797	1.16	1.19	2	4	2	0	100%	1
5NV9_LMT_A_504	99%	31%	0.045	0.983	0.57	2.12	-	12	1	0	100%	1
3CAY_LMT_A_512	94%	59%	0.071	0.968	0.66	0.9	-	1	0	0	100%	1
4U8Y_LMT_C_1101	83%	64%	0.096	0.953	0.43	0.92	-	1	2	0	100%	1
3SZF_LMT_A_501	73%	33%	0.101	0.928	1.23	1.44	3	5	2	0	100%	1
3T14_LMT_A_501	72%	31%	0.12	0.945	1.21	1.54	3	10	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.